Comprehensive COVID-19 Slideset: Special Populations and Comorbidities

Clinical Care Options’ (CCO) commentary from Dr. Vikramjit Mukherjee on the association between surges in COVID-19 caseload and mortality.

Vikramjit Mukherjee, MD Released: September 3, 2021

Downloadable slides from CCO on the rationale and evidence supporting timeliness in the administration of therapies that act directly against SARS-CoV-2

Arthur Kim, MD Lynora Saxinger, MD, FRCPC, CTropMed Released: August 25, 2021

Concise Clinical Care Options (CCO) presentation by Arthur Kim, MD, on emerging oral antiviral options for outpatient treatment of SARS-CoV-2 infection

Arthur Kim, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: August 25, 2021 Expired: August 24, 2022

From Dr. Josep M. Llibre and Clinical Care Options (CCO), expert commentary reviewing recent data about the potential therapeutic role of TDF in SARS-CoV-2 infection

Josep M. Llibre, MD, PhD Released: August 16, 2021